Cargando…
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
INTRODUCTION: Translational inhibition of amyloid precursor protein (APP) by Posiphen has been shown to reduce APP and its fragments in cell culture, animal models, and mildly cognitively impaired patients, making it a promising drug candidate for the treatment of Alzheimer's disease. METHODS:...
Autores principales: | Teich, Andrew F., Sharma, Ekta, Barnwell, Eliza, Zhang, Hong, Staniszewski, Agnieszka, Utsuki, Tadanobu, Padmaraju, Vasudevaraju, Mazell, Cheryl, Tzekou, Apostolia, Sambamurti, Kumar, Arancio, Ottavio, Maccecchini, Maria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021259/ https://www.ncbi.nlm.nih.gov/pubmed/29955650 http://dx.doi.org/10.1016/j.trci.2017.12.001 |
Ejemplares similares
-
Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
por: Chen, Xu‐Qiao, et al.
Publicado: (2020) -
Posiphen Reduces the Levels of Huntingtin Protein through Translation Suppression
por: Chen, Xu-Qiao, et al.
Publicado: (2021) -
Evidence of a Novel Mechanism for Partial γ-Secretase Inhibition Induced Paradoxical Increase in Secreted Amyloid β Protein
por: Barnwell, Eliza, et al.
Publicado: (2014) -
Cell Biology Apps for Apple Devices
por: Stark, Louisa A.
Publicado: (2012) -
Apps: A way to accelerate recovery?
por: Westgarth, David
Publicado: (2021)